Immunovant, Inc. SC 13G and SC 13G/A reports

Location
320 West 37 Th Street, New York, NY
State of incorporation
DE
Fiscal year end
March 31
Data updated at
2/6/2025, 06:46 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Nov 12, 2024
SC 13G/A Report Feb 14, 2024
SC 13G Report Feb 9, 2024
SC 13G/A Report Feb 14, 2023
SC 13G/A Report SC 13G/A Dec 5, 2022
SC 13G/A Report SC 13G/A Dec 2, 2022
SC 13G Report Feb 11, 2022
SC 13G/A Report Feb 16, 2021
SC 13G/A Report Apr 9, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report AMENDMENT NO. 1 Feb 14, 2020
SC 13G/A Report Feb 12, 2020
SC 13G/A Report IMMUNOVANT, INC. Feb 12, 2020
SC 13G Report Oct 8, 2019
SC 13G Report SCHEDULE 13G May 22, 2019
SC 13G Report May 20, 2019
SC 13G Report HEALTH SCIENCES ACQUISITIONS CORPORATION May 20, 2019